Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ALISON MOORE Insider Profile
4 Followers
ALISON MOORE, CTO at Allogene Therapeutics, holds 148.70K shares in Codexis (Ticker: CDXS), holds 672.73K shares in Allogene Therapeutics (Ticker: ALLO), holds ― shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV).
ALISON MOORE has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that ALISON MOORE holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by ALISON MOORE
ALISON MOORE's Trading History
Allogene Therapeutics
Mar 24, 2023
CTO
Uninformative Buy
―
$1.49M
Codexis
Oct 10, 2024
CTO
Uninformative Buy
―
$685.49K
Artiva Biotherapeutics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see ALISON MOORE's performance on stock
You May Also Like
ALISON MOORE insider profile FAQ
What is the percentage of profitable transactions made by ALISON MOORE?
The percentage of profitable transactions made by ALISON MOORE is ―.
What is the average return per transaction made by ALISON MOORE?
The average return per transaction made by ALISON MOORE is ―.
What stocks does ALISON MOORE hold?
ALISON MOORE holds: ALLO, CDXS, ARTV stocks.
What was ALISON MOORE’s latest transaction?
ALISON MOORE latest transaction was an Uninformative Buy of ―.
What was ALISON MOORE's most profitable transaction?
ALISON MOORE’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is ALISON MOORE's role in Allogene Therapeutics?
ALISON MOORE's role in Allogene Therapeutics is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.